Sign In
Buy PRTK
$2.23
+0 (+0%)
At Close: Dec 19, 2023
Paratek Pharmaceuticals (PRTK) Reports Q4 Loss, Tops Revenue Estimates
12:55pm, Thursday, 16'th Mar 2023 Zacks Investment Research
Paratek (PRTK) delivered earnings and revenue surprises of -1,300% and 33.06%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Paratek Pharmaceuticals Announces Full-Year 2022 Revenue of $160.3 Million
11:30am, Thursday, 16'th Mar 2023 GlobeNewswire Inc.
-- NUZYRA® (omadacycline) Generated Net U.S. Sales of $98.7 Million from the Core Commercial Business, a 45% Increase Over the Prior Year
Agenus (AGEN) Reports Q4 Loss, Tops Revenue Estimates
12:45pm, Tuesday, 14'th Mar 2023 Zacks Investment Research
Agenus (AGEN) delivered earnings and revenue surprises of -9.09% and 59.25%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Paratek Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on March 16
01:30pm, Wednesday, 08'th Mar 2023 GlobeNewswire Inc.
BOSTON, March 08, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) today announced that the company will host a conference call and live audio webcast on Thursday, March 16, 202
Paratek Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on March 16
08:30am, Wednesday, 08'th Mar 2023
BOSTON, March 08, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) today announced that the company will host a conference call and live audio webcast on Thursday, March 16, 2023
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
09:05pm, Wednesday, 01'st Mar 2023 GlobeNewswire Inc.
BOSTON, March 01, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-s
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
09:05pm, Wednesday, 01'st Feb 2023 GlobeNewswire Inc.
BOSTON, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-sa
Paratek Pharmaceuticals Announces Inclusion of NUZYRA® (omadacycline) in China’s National Reimbursement Drug List (NRDL)
12:00pm, Wednesday, 18'th Jan 2023 GlobeNewswire Inc.
National Healthcare Security Administration Adds NUZYRA to NRDL for Treatment of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infections National Healthcare Secur
Paratek Pharmaceuticals Appoints Jeffrey Stein as Lead Independent Director of the Board
12:30pm, Tuesday, 20'th Dec 2022 GlobeNewswire Inc.
BOSTON, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) today announced that the Company’s independent directors of the Board have appointed Jeffrey Stein, PhD as its
BOSTON, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) today announced positive top line data from a pilot rabbit efficacy study evaluating NUZYRA’s effectiveness i
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
10:45pm, Thursday, 01'st Dec 2022 GlobeNewswire Inc.
BOSTON, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-sa
Paratek Pharmaceuticals to Present at the 5th Annual Evercore ISI HealthCONx Conference
04:05pm, Monday, 21'st Nov 2022
BOSTON, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-savi
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
08:07am, Monday, 07'th Nov 2022 Benzinga
Gainers
Peak Bio, Inc. (NASDAQ: PKBO) shares surged 105.8% to close at $7.82 on Friday. Peak Bio reported closing of up to $100 million common stock purchase transaction with White Lion Capital. Lade
Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session
04:54pm, Friday, 04'th Nov 2022 Benzinga
Gainers
Peak Bio, Inc. (NASDAQ: PKBO) jumped 115% to $8.17. Peak Bio reported closing of up to $100 million common stock purchase transaction with White Lion Capital. Ladenburg Thalmann initiated cov
Paratek Pharmaceuticals Announces Third Quarter 2022 Revenue of $30.2 Million
08:05pm, Thursday, 03'rd Nov 2022 GlobeNewswire Inc.
-- NUZYRA® (omadacycline) Generated Net U.S. Sales of $25.5 Million from the Core Commercial Business, a 31% increase from $19.4 Million in Third Quarter 2021
